Overview

Atorvastatin in Moderate Active Crohns Disease

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
Open pilot study to collect information regarding the effect of atorvastatin on patients with active Crohns disease.
Phase:
Phase 2
Details
Lead Sponsor:
Skane University Hospital
Treatments:
Atorvastatin
Atorvastatin Calcium